Back
 ABCR  Vol.9 No.4 , October 2020
Benefits and Limitations of Volumetric Modulated Arc Therapy in Treating Bilateral Breast Cancer with Regional Lymph Nodes
Abstract: Purpose: The study was performed comparing dosimetric characteristics of volumetric modulated arc therapy (VMAT) and field-in-field (FiF) techniques on a patient with synchronous bilateral breast carcinoma. Methods: The patients with bilateral breast cancer treatment were included in this study. A total dose of 40.05 Gy in 15 fractions was prescribed to the Planning Target Volume (PTV) of the whole bilateral breast cancer with the supraclavicular and infraclavicular nodes, with a complementary boost of 10 Gy in 4 fractions to the surgical bed (PTVboost). For both radiotherapy techniques, several VxGy parameters were analyzed for the PTVs, together with the Conformity index (CI), the Homogeneity index (HI) and the critical organs at risk (OARs), lungs and heart. Results: The patient was treated by the VMAT technique and the daily treatment time was less than 20 minutes with daily CBCT imaging. In the VMAT plan, the PTV 95% dose covered 38.89 ± 0.81 Gy, compared to 37.26 ± 1.02 Gy in the FiF technique. The VMAT plan improved the dose homogeneity index and lower dose in lung towards high dose region. Conclusion: The study demonstrates the viability of the VMAT technique in the treatment of bilateral breast cancer. The introduced single isocentric VMAT technique is fast to deliver and it increases the dose homogeneity of the target volume with some limitations. The treatment was well tolerated, without interruption of the treatment courses caused by treatment-related toxicities.
Cite this paper: Srivastava, R. , Vandeputte, K. and Wagter, C. (2020) Benefits and Limitations of Volumetric Modulated Arc Therapy in Treating Bilateral Breast Cancer with Regional Lymph Nodes. Advances in Breast Cancer Research, 9, 119-126. doi: 10.4236/abcr.2020.94010.
References

[1]   Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492

[2]   Kheirelseid, E.A.H., Jumustafa, H., Miller, N., et al. (2011) Bilateral Breast Cancer: Analysis of Incidence, Outcome, Survival and Disease Characteristics. Breast Cancer Research and Treatment, 126, 131-140.
https://doi.org/10.1007/s10549-010-1057-y

[3]   Selvakumar, V.P.P., Garg, S., Siddiqui, K., Goel, A., Kumar, K. and Kumar, R. (2015) Tailored Approach to Management of Bilateral Breast Cancer in Indian Women. Asian Journal of Oncology, 1, 97-100.
https://doi.org/10.4103/2454-6798.173311

[4]   Gong, S.J., Rha, S.Y., Jeung, H.C., Roh, J.K., Yang, W.I. and Chung, H.C. (2007) Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters. Japanese Journal of Clinical Oncology, 37, 487-492.
https://doi.org/10.1093/jjco/hym056

[5]   Yamauchi, C., Mitsumori, M., Nagata, Y., et al. (2005) Bilateral Breast-Conserving Therapy for Bilateral Breast Cancer: Results and Consideration of Radiation Technique. Breast Cancer, 12, 135-139.
https://doi.org/10.2325/jbcs.12.135

[6]   Kim, S.J., Lee, M.J. and Youn, S.M. (2018) Radiation Therapy of Synchronous Bilateral Breast Carcinoma (SBBC) Using Multiple Techniques. Medical Dosimetry, 43, 55-68.
https://doi.org/10.1016/j.meddos.2017.08.003

[7]   Giorgia, N., Antonella, F., Alessandro, C., Eugenio, V. and Luca, C. (2011) Planning Strategies in Volumetric Modulated Are Therapy for Breast. Medical Physics, 38, 4025-4031.
https://doi.org/10.1118/1.3598442

[8]   Depuydt, T., Van Esch, A. and Huyskens, D.P. (2002) A Quantitative Evaluation of IMRT Dose Distributions: Refinement and Clinical Assessment of the Gamma Evaluation. Radiotherapy & Oncology, 62, 309-319.
https://doi.org/10.1016/S0167-8140(01)00497-2

[9]   Seppala, J., Heikkila, J., Myllyoja, K. and Koskela, K. (2015) Volumetric Modulated Arc Therapy for Synchronous Bilateral Whole Breast Irradiation—A Case Study. Reports of Practical Oncology & Radiotherapy, 20, 398-402.
https://doi.org/10.1016/j.rpor.2015.05.011

[10]   Ricotti, R., Ciardo, D., Fattori, G., et al. (2017) Intra-Fraction Respiratory Motion and Baseline Drift During Breast Helical Tomotherapy. Oncology & Radiotherapy, 122, 79-86.
https://doi.org/10.1016/j.radonc.2016.07.019

[11]   Fiorentino, A., Mazzola, R., Naccarato, S., et al. (2017) Synchronous Bilateral Breast Cancer Irradiation: Clinical and Dosimetrical Issues Using Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost. La Radiologia Medica, 122, 464-471.
https://doi.org/10.1007/s11547-017-0741-y

[12]   Galecki, J., Beczkowska, K. and Mezeński, P. (2017) Volumetric Modulated Arc Therapy Followed By Bilateral Mastectomy for Treating Synchronous Cancer and Sarcoma—A Rare Case Report. Nowotwory, 67, 48-53.
https://doi.org/10.5603/NJO.2017.0007

[13]   Abo-Madyan, Y., Aziz, M.H., Aly, M.M., et al. (2014) Second Cancer Risk after 3D-CRT, IMRT and VMAT for Breast Cancer. Radiotherapy and Oncology, 110, 471-476.
https://doi.org/10.1016/j.radonc.2013.12.002

[14]   Malicki, J. (2012) The Importance of Accurate Treatment Planning, Delivery, and Dose Verification. Reports of Practical Oncology & Radiotherapy, 17, 63-65.
https://doi.org/10.1016/j.rpor.2012.02.001

[15]   Lee, B., Lee, S., Sung, J. and Yoon, M. (2014) Radiotherapy-Induced Secondary Cancer Risk for Breast Cancer: 3D Conformal Therapy versus IMRT versus VMAT. Journal of Radiological Protection, 34, 325-331.
https://doi.org/10.1088/0952-4746/34/2/325

[16]   Cendales, R., Schiappacasse, L., Schnitman, F., García, G. and Marsiglia, H. (2011) Helical Tomotherapy in Patients with Breast Cancer and Complex Treatment Volumes. Clinical and Translational Oncology, 13, 268-274.
https://doi.org/10.1007/s12094-011-0652-7

[17]   Darby, S.C., Ewertz, M., Mcgale, P., et al. (2013) Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. New England Journal of Medicine, 368, 987-998.
https://doi.org/10.1056/NEJMoa1209825

 
 
Top